FSCN1 and metastatic neoplasm: ,5,11,12 Systematic reviews and meta-analyses have revealed that FSCN1 is correlated with increased mortality risks and metastasis in various cancer types, is a novel biomarker for the identification of aggressive and metastatic tumors,12 and is a prognostic marker of overall survival.13